Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma.
Liu X, Xu S, Zhang J, Fan M, Xie J, Zhang B, Li H, Yu G, Liu Y, Zhang Y, Song J, Horne D, Chan WC, Chu X, Huang W.
Liu X, et al. Among authors: fan m.
Hematol Oncol. 2022 Aug;40(3):356-369. doi: 10.1002/hon.3010. Epub 2022 May 5.
Hematol Oncol. 2022.
PMID: 35482553
Free PMC article.